期刊文献+

应用清醒大鼠遥测模型评价AF114注射液的心血管系统的安全性 被引量:4

Establishment of a telemetry model in conscious rats for evaluating the cardiovascular safety of AF114 injection
原文传递
导出
摘要 目的:应用可在清醒自由活动状态下长期监测心血管系统参数和体温变化的大鼠遥测模型评价AF114注射液对心血管系统及体温的影响。方法:通过手术将可遥测大鼠血压、心电图、体温的植入体植入大鼠体内,建立清醒大鼠遥测模型。经颈静脉置入导管,经皮下穿刺将导管从颈后侧引出,固定,用于给药或采血。动物术后恢复1周,用阳性药物垂体后叶素验证模型的反应性。验证后用该模型评价AF114注射液对心血管系统及体温的影响。结果:32只大鼠手术后有29只恢复良好,无感染,均可监测到腹主动脉血压、心电图、体温等生理信号。经腹腔注射给予清醒大鼠垂体后叶素1 U.kg-1后,观察到平均动脉压升高,射血时间延长,体温降低,心率减慢。经静脉注射给予AF114注射液后,引起大鼠平均动脉压升高,心率加快,体温升高,对血小板计数和红细胞计数无明显影响。结论:清醒大鼠心血管遥测模型可用于长期、连续、动态监测心血管功能;静脉注射AF114注射液后可引起清醒大鼠血压升高、心率加快和体温升高。 Objective: To establish an animal model that can long-term monitor the cardiovascular parameters and body temperature in conscious and freely moving telemetry rats,and utilizing this model to evaluate the effects of AF114 injection on the cardiovascular parameters and body temperature.Methods: A transmitter body that can monitor BP,ECG,body temperature and activities was implanted in the cavity of the rats.A catheter was inserted in jugular vein for administration of saline and AF114 injection,or for collecting blood samples.After a week recovery,pituitary was used as a positive drug to test the reactivity of the telemetry rat model.Then we utilized this model to evaluate the effect of AF114 injection on the cardiovascular parameters and body temperature.Results: Of the 32 operated rats 29 rats recovered well,and their BP,ECG and body temperature were monitored.The conscious telemetered rat model was successfully established.After ip injection of pituitary 1 U·kg-1 BW,the mean blood pressure was increased,ejection time was prolonged,and body temperature and heart rate were decreased.After iv AF114 injection,the mean blood pressure,heart rate and body temperature were increased.AF114 had no effect on the platelet count and red blood cell count.Conclusion: We have successfully established an animal model that can monitor the cardiovascular parameters and body temperature in conscious and freely moving telemetry rats.AF114 injection can increase blood pressure,heart rate and body temperature in the conscious rats.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第22期2188-2194,共7页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项(2009ZX09501-034)
关键词 清醒动物 遥测 安全性药理学 药物安全性评价 conscious animal telemetry safety pharmacology drug safety evaluation
  • 相关文献

参考文献11

  • 1KRAMER K, KINTER L, BROCKWAY BP, et al. The use of radiotelemetry in small laboratory animals: recent advances [ J ]. Contemp Top Lab Anita Sci, 2001, 40( 1 ) : 8 - 16.
  • 2KURTZ TW, GRIFFIN KA, BIDANI AK, et al. Recommenda- tions for blood pressure measurement in humans and experimental animals : part 2 : blood pressure measurement in experimental an- imals : a statement for professionals from the Subcommittee of Pro- fessional and Public Education of the American Heart Association Council on High Blood Pressure Research [ J ]. Arteriuscler Thromb Vasc Biol, 2005, 25(3) : 22 -33.
  • 3ICH. Safety pharmacology studies for human pharmaceuticals [ EB/OL]. (2000 - 11 - 10). http ://private. ich. org/LOB/media/ MEDIAS0d. pdf.
  • 4ICH. The nonclinical evaluation of the potential for delayed ven- tricular repolarization ( QT Interval Prolongation) by human phar-maceuticais [ EB/OL ]. (2005 - 05 - 12 ). http ://private. ich. org/LOB/media/MEDIA504, pdf.
  • 5同家食品药品监督管理局.化学药物一般药理学研究技术指导原则[EB/OL](2005一03-18).http://www.sda.gov.on/WS01/CL0055/10368.html.
  • 6国家食品药品家督管理局.中药、天然药物一般药理学研究技术指导原则[EB/OL].(2005-03-18).http://www.ode.org.en/zdyz.do?method=largePage&id=2091.
  • 7SIVARAJAH A, COLLINS S, SUTTON MR, et al. Cardiovascu- lar safety assessments in the conscious telemetered dog: uti|isati- on of super-intervals to enhance statistical power[ J]. J Pharma- col Toxicol Methods, 2010, 62( 1 ): 12- 19.
  • 8RATH DP, LITTLE CM, ZHANG H, et a], Sodium pentobarbi- tal versus alpha-chloralose anesthesia. Experimental production of substantially different slopes in the transmural CP/ATP ratios within the left ventricle of the canine myocardium [ J ]. Circula- tion, 1995, 91(2) : 471 -475.
  • 9BOUCHER M, DUBRAY C, LI JH, et al. Influence of pento- barbital and chloraluse anesthesia on quinidine-induced effects on atrial refractoriness and heart rate in the dog [ J ]. J Cardiovasc Pharmacol, 199l, 17(2): 199-206.
  • 10BALDRICK P. Safety evaluation to support First-In-Man investi- gations I: kinetic and safety pharmacology studies [ J]. Regul Toxicol Pharmacol, 2008, 51 ( 2 ) : 230 - 236.

二级参考文献19

  • 1VALENTIN JP, BASS AS, ATRAKCHI A, et al. Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A[J]. J Pharmacol Toxicol Methods,2005, 52 (1) :22 -29.
  • 2DEWHURST M, ADEYEMI O, HARRIS J, et al. Application of modified ECG lead placement technique in rat telemetry safety studies: outcome and potential use [ J ]. J Pharmacol Toxicol Methods,2008, 58(2) :147 - 178.
  • 3AUTHIER S, TANGUAY JF, GAUVIN D, et al. A cardiovascular monitoring system in cynomolgus monkeys for regulatory safety pharmacology, Part 1 : Non-pharmacological validation [ J ]. J Pharmacol Toxicol Methods,2007, 56 ( 2 ) : 115 - 121.
  • 4CHIANG AY, SMITH WC, MAIN BW, et al. Statistical power analysis for hemodynamic cardiovascular safety pharmacology studies in beagle dogs[ J]. J Pharmacol Toxicol Methods, 2004, 50(2) :121 - 130.
  • 5AUTHIER S, TANGUAY JF, FOURNIER S, et al. Conscious and anesthetized non-human primate safety pharmacology models: Hemodynamic sensitivity comparison [ J ]. J Pharmacol Toxicol Methods ,2008, 58 ( 2 ) :94 - 98.
  • 6BALDRICK P. Safety evaluation to support First-In-Man investigations Ⅰ: kinetic and safety pharmacology studies [ J ]. J Regul Toxicol Pharm,2008, 51 ( 2 ) :230 - 236.
  • 7SNYDER S. Safety pharmacology, part 1 of a 2-part interview with an industry expert, preclinical outsourcing [ EB/OL ]. ( 2008 - 09 - 10 ). http ://www. contractpharma. com.
  • 8CHAVES AA, KELLER WJ, O'SULLIVAN S, et al. Cardiovascular monkey telemetry: Sensitivity to detect QT interval prolongation [ J ]. J Pharmacol Toxicol Methods, 2006, 54 (2) : 150 - 158.
  • 9CAVERO I. Safety Pharmacology Society: 7th annual meeting, Edinburgh, UK. Expert Opinion Drug Safety[ C]. 2008.
  • 10EGAN JE, ZLOKARNIK G, GROOTENHUIS PDJ. In silico prediction of drug safety : despite progress there is abundant room for improvement [ J ]. Drug Discov Today, 2004, 1 (4) : 381 - 387.

共引文献8

同被引文献38

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部